These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 3403257)

  • 1. The effect of dopamine receptor agonists on prolactin secretion in childhood migraine.
    D'Andrea G; Cananzi AR; Grigoletto F; Meneghini F; Cortesi S; Soffiati G; Joseph R; Nordera G; Ferro-Milone F
    Headache; 1988 Jun; 28(5):354-9. PubMed ID: 3403257
    [No Abstract]   [Full Text] [Related]  

  • 2. Growth hormone and prolactin secretion in liver cirrhosis: evidence for dopaminergic dysfunction.
    Borzio M; Caldara R; Ferrari C; Barbieri C; Borzio F; Romussi M
    Acta Endocrinol (Copenh); 1981 Aug; 97(4):441-7. PubMed ID: 7270004
    [No Abstract]   [Full Text] [Related]  

  • 3. Elevation of 3, 4-dihydroxyphenylacetic acid concentrations in rat brain and stimulation of prolactin secretion by fenfluramine: evidence for antagonism at dopamine receptor sites.
    Fuller RW; Perry KW; Clemens JA
    J Pharm Pharmacol; 1976 Aug; 28(8):643-4. PubMed ID: 11315
    [No Abstract]   [Full Text] [Related]  

  • 4. Failure of 2 Hydroxyestradiol to interact with dopamine inhibition of human prolactin secretion in vitro and with dopamine receptors of prolactin-secreting adenomas.
    Peillon F; Brandi AM; Bression D; Le Dafniet M; Racadot J
    Biochem Biophys Res Commun; 1983 Apr; 112(1):42-6. PubMed ID: 6838618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolactin and migraine.
    Murialdo G; Polleri A
    Headache; 1987 May; 27(5):278-9. PubMed ID: 3597085
    [No Abstract]   [Full Text] [Related]  

  • 6. The prolactin response in clinical psychiatry.
    Gruen PH
    Med Clin North Am; 1978 Mar; 62(2):409-24. PubMed ID: 347199
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibition by lithium of dopamine receptors in rat prolactin release.
    Tanimoto K; Maeda K; Chihara K
    Brain Res; 1981 Nov; 223(2):335-42. PubMed ID: 6269703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of flupenthixol and butaclamol isomers on prolactin secretion in rats.
    Meltzer HY; Paul SM; Fang VS
    Psychopharmacology (Berl); 1977 Jan; 51(2):181-3. PubMed ID: 14352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine receptor and adrenoceptor agonists inhibit prolactin release from MMQ cells.
    Judd AM; MacLeod RM
    Eur J Pharmacol; 1991 Mar; 195(1):101-6. PubMed ID: 1676676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulsatile gonadotropin secretion and basal prolactin levels during dopamine D-1 receptor stimulation in normal women.
    Boesgaard S; Hagen C; Hangaard J; Andersen AN; Eldrup E
    Fertil Steril; 1991 Feb; 55(2):281-6. PubMed ID: 1671361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. l-deprenyl test in migraine: neuroendocrinological aspects.
    Calabresi P; Silvestrini M; Stratta F; Cupini LM; Argiro G; Atzei GP; Bernardi G
    Cephalalgia; 1993 Dec; 13(6):406-9. PubMed ID: 8313454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perlapine: relationship between stimulation of prolactin secretion and antipsychotic activity.
    Meltzer HY; Fessler RG; Fang VS
    Psychopharmacology (Berl); 1977 Oct; 54(2):183-6. PubMed ID: 412213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in the dopaminergic control of prolactin secretion and in ovarian steroids in migraine.
    Murialdo G; Martignoni E; De Maria A; Bonura ML; Sances G; Bono G; Polleri A
    Cephalalgia; 1986 Mar; 6(1):43-9. PubMed ID: 3698093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine and migraine.
    Peroutka SJ
    Neurology; 1997 Sep; 49(3):650-6. PubMed ID: 9305317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolactin secretion in Parkinson disease.
    Eisler T; Thorner MO; MacLeod RM; Kaiser DL; Calne DB
    Neurology; 1981 Oct; 31(10):1356-9. PubMed ID: 6810204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of different Ca2+ entry blockers on dopamine-induced inhibition of in vitro prolactin secretion.
    Di Renzo G; Amoroso S; Maida P; Canzoniero L; Nappi C; Taglialatela M; Annunzia L
    Eur J Pharmacol; 1988 Feb; 146(2-3):201-6. PubMed ID: 3371396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of lithium on hypothalamic-pituitary dopaminergic function.
    Lal S; Nair NP; Guyda H
    Acta Psychiatr Scand; 1978 Jan; 57(1):91-6. PubMed ID: 636903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine involvement in the migraine attack.
    Fanciullacci M; Alessandri M; Del Rosso A
    Funct Neurol; 2000; 15 Suppl 3():171-81. PubMed ID: 11200788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolactin secretion from human prolactinomas perifused in vitro: effect of TRH, prostaglandin E1, theophylline, dopamine and dopamine receptor blockers.
    Chihara K; Iwasaki J; Minamitani N; Kaji H; Kodama H; Fujita T; Shirataki K; Tamaki N; Matsumoto S
    Acta Endocrinol (Copenh); 1984 Jan; 105(1):6-13. PubMed ID: 6421041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pharmacology of sulpiride--a dopamine receptor antagonist.
    O'Connor SE; Brown RA
    Gen Pharmacol; 1982; 13(3):185-93. PubMed ID: 7047291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.